Myant and Coapt Collaborate to Enhance Assistive Technology with Textile-Based Neural Interfaces
In a groundbreaking partnership unveiled on December 6, 2024, Myant Corp., a trailblazer in the realm of textile computing for healthcare, has joined forces with Coapt, a leading developer of neural interface technology. Their collaboration is set to disrupt the existing landscape of assistive technology and pain management, focusing on the creation of textile-based electromyographic (EMG) interfaces designed to better connect prosthetics and other therapeutic devices to the human body.
This innovative initiative combines Coapt's state-of-the-art EMG Intent Decoder control systems with Myant's advanced textile technologies, aiming to produce new products that enhance comfort, precision, and control for users of assistive devices such as prosthetics. By harnessing their collective expertise, they aspire to develop solutions that address phantom pain and offer biofeedback mechanisms, thereby advancing Myant's mission to enrich the lives of individuals with unique needs.
Tony Chahine, CEO of Myant, expressed, "Myant and Coapt share a vision of enhancing quality of life through the seamless integration of technology with the human body. This partnership will push the boundaries of what is possible in prosthetics and rehabilitation."
Looking ahead, Myant and Coapt have strategic plans for exploring applications of virtual and augmented reality in medical therapies, which will also include funded research and clinical trials aimed at understanding the broader impacts of their combined technologies for patients around the globe. According to Blair Lock, CEO of Coapt, "Together, Coapt and Myant are creating a future where assistive technologies not only help individuals regain function but also enhance their overall well-being and autonomy."
Myant is gearing up to showcase their latest innovations at the Consumer Electronics Show (CES) from January 7-10, 2024, in Las Vegas, USA. Live demonstrations featuring Coapt will exhibit how they plan to accelerate the introduction of next-generation assistive technologies while fostering meaningful connections with the global health community.
About Myant
Myant's mission is to enable and enhance quality of life for everyone. By leveraging advancements in AI, medicine, and innovative materials, Myant promotes health, safety, connection, and confidence throughout all life stages. The company leads in ushering a new era where AI guardians enhance human capabilities through textile interfaces that function like a connected second skin. This skin, composed of cutting-edge materials, naturally integrates into daily life and sets new standards for seamless interaction with the digital realm.
From birth to old age, AI guardians enrich our daily lives, foster wellness, ensure safety, redefine connections with society, and promote universal access to optimal healthcare.
In 2024, Myant expanded significantly into the EU, recruiting renowned AI scientist Dr. Xin Gao as Chief AI Officer.
For more information about Myant, visit
www.myant.ca
About Coapt
Coapt, LLC is a private company based in Chicago, USA, with a research subsidiary, Liberating Technologies, Inc. in Boston, USA. Founded in 2012, Coapt quickly launched Complete Control, an FDA Class II approved myoelectric, machine-learning prosthetic control system. This flagship product - now in its second generation - was the first technology to allow users to operate advanced arm and hand prosthetics naturally. Complete Control employs clinically developed artificial intelligence to learn and adapt to users' unique muscle signal patterns, enabling intuitive, intentional control of bionic upper limbs. Coapt's myoelectric pattern recognition products are compatible with over 450 different prosthetic configurations. Beyond its outstanding product lineup, Coapt has forged strong partnerships within the industry and boasts a robust academic research portfolio.
For more information on Coapt, check out
coaptengineering.com.
About Textile Computing™
Myant integrates sensors and actuators into everyday textiles, creating a textile interface that continuously perceives and reacts to the human body. The goal is to empower humanity to transform our abilities, proactively manage health, deliver swift treatments, and foster better connections with ourselves and others.
Upcoming Event - CES 2025
Myant will be present from January 7-10, 2025, at Booth #53617 in the Venetian Expo Convention Center, 201 Sands Ave., Las Vegas, NV 89169, USA.
For media inquiries, please contact: Charles Andreo.
Email:
[email protected]